Sorafenib-Induced Autophagy Promotes Glycolysis by Upregulating the p62/HDAC6/HSP90 Axis in Hepatocellular Carcinoma Cells.

Yan X, Tian R, Sun J, Zhao Y, Liu B, Su J, Li M, Sun W, Xu X.

Open source

DOI
10.3389/fphar.2021.788667
Published
2022-02-16
Container
Front Pharmacol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2021.788667,
  title = {Sorafenib-Induced Autophagy Promotes Glycolysis by Upregulating the p62/HDAC6/HSP90 Axis in Hepatocellular Carcinoma Cells.},
  author = {Yan X and  Tian R and  Sun J and  Zhao Y and  Liu B and  Su J and  Li M and  Sun W and  Xu X.},
  year = {2021},
  journal = {Front Pharmacol},
  doi = {10.3389/fphar.2021.788667},
  url = {https://doi.org/10.3389/fphar.2021.788667}
}

RIS

TY  - JOUR
TI  - Sorafenib-Induced Autophagy Promotes Glycolysis by Upregulating the p62/HDAC6/HSP90 Axis in Hepatocellular Carcinoma Cells.
AU  - Yan X
AU  -  Tian R
AU  -  Sun J
AU  -  Zhao Y
AU  -  Liu B
AU  -  Su J
AU  -  Li M
AU  -  Sun W
AU  -  Xu X.
PY  - 2021
JO  - Front Pharmacol
DO  - 10.3389/fphar.2021.788667
UR  - https://doi.org/10.3389/fphar.2021.788667
ER  - 

APA

X, Y., R, T., J, S., Y, Z., B, L., J, S., M, L., W, S., & X., X. (2021). Sorafenib-Induced Autophagy Promotes Glycolysis by Upregulating the p62/HDAC6/HSP90 Axis in Hepatocellular Carcinoma Cells.. Front Pharmacol. https://doi.org/10.3389/fphar.2021.788667

Source records